<!DOCTYPE html>

<html>
  <head>
    <title>BCNscreening</title>
    <meta charset="utf-8" />
    <meta
      name="viewport"
      content="width=device-width, initial-scale=1, user-scalable=no"
    />
    <link rel="stylesheet" href="assets/css/main.css" />
  </head>
  <body class="is-preload">
  
    <div id="page-wrapper">
      <!-- Wrapper -->
      <div class="wrapper">
        <div class="inner">
          <!-- Header -->
          <header id="header">
            <span class="miga"><a href="index.html"
              ><span class="depan">MÓDULO 3</span>&nbsp;</a
              ><span><a href="M3biblio.html"
                ><i class="arrow right"></i>&nbsp;&nbsp;<span class="depan1">Bibliografía</span></a></span></span>
            <nav>
              <ul>
                <li><a href="#menu"></a></li>
              </ul>
            </nav>

          </header>

          <!-- Nav -->

          <nav id="menu">
            <h4>ÍNDICE</h4>

            <ul class="links">
              <li><a href="M31_1.html">&nbsp;Unidad 1</a></li>
              <li><a href="M32_1.html">&nbsp;Unidad 2</a></li>
              <li><a href="M33_1.html">&nbsp;Unidad 3</a></li>
              <li><a href="M34_1.html">&nbsp;Unidad 4</a></li>
            </ul>
            <h4>RECURSOS</h4>
            <ul class="links">
              <li><a href="M3summary.html">&nbsp;Resumen</a></li>
              <li><a href="M3biblio.html">&nbsp;Bibliografía</a></li>
              <li>
                <a href="docs/PDF_03.pdf" target="_blank"
                  >&nbspContenido en PDF</a
                >
              </li>
            </ul>
          </nav>
          <!-- Summary -->
          <section class="main">
            <header class="major">
              <h1>BIBLIOGRAFÍA</h1>
              <h4>Revisiones</h4>
            </header>
            <ul class="alt circulito">
              <li>Kyrgiou M, Arbyn M, Bergeron C, Bosch FX, Dillner J, Jit M, et al. Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC). Br J Cancer. 2020 Jun 8;123(4):510–7.

              </li><li>Schiffman M, Doorbar J, Wentzensen N, de Sanjosé S, Fakhry C, Monk BJ, et al. Carcinogenic human papillomavirus infection. Nat Rev Dis Primers. 2016 Dec 1;2(1):1–20.
                
              </li><li>Singer A, Khan A. Cervical cancer screening. In: Cancer Prevention and Screening. John Wiley & Sons, Ltd; 2018 [cited 2020 Oct 27]. p. 81–100.
                
              </li><li>Shiraz A, Crawford R, Egawa N, Griffin H, Doorbar J. The early detection of cervical cancer. The current and changing landscape of cervical disease detection. Cytopathology. 2020 Jul;31(4):258–70.
                
              </li><li>Tota JE, Bentley J, Blake J, Coutlée F, Duggan MA, Ferenczy A, et al. Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm. Prev Med. 2017 May;98:5–14.
                
              </li><li>Iftner T. Are HPV DNA or HPV E6/E7 mRNA tests the better solution for Cervical Cancer Screening? HPV World [Internet]. 2018;(56). Disponible en: www.hpvworld.com
                
              </li><li>Cubie HA, Campbell C. Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi. Womens Health (Lond Engl). 2020 Dec;16:1745506520914804.
                
              </li><li>Wright Jr. TC, Kuhn L. Alternative approaches to cervical cancer screening for developing countries. Best Practice & Research Clinical Obstetrics & Gynaecology. 2012 Apr;26(2):197–208.</li>
            </ul>
                <hr />
                <header class="major">
                  <h4>REFERENCIAS ESPECÍFICAS MENCIONADAS</h4>
                </header>
                <ol class="alt">
                <li>Cuzick J, Clavel C, Petry K-U, Meijer CJLM, Hoyer H, Ratnam S, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006;119(5):1095–101.

                </li><li>Leyden WA, Manos MM, Geiger AM, Weinmann S, Mouchawar J, Bischoff K, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst 2005;97(9):675–83.
                  
                </li><li>Danckert B, Ferlay J, Engholm G, Hansen HL, Johannesen TB, Khan S, et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 8.2 (26.03.2019) [Internet]. Association of the Nordic Cancer Registries. Danish Cancer Society.; [cited 2020 Nov 19]. Disponible <a href="https://www-dep.iarc.fr/nordcan/english" target="_blank">aquí <span class="icon solid fa-external-link-alt"></span></a>. 
                  
                </li><li>Wang J, Andrae B, Strander B, Sparén P, Dillner J. Increase of cervical cancer incidence in Sweden in relation to screening history: population cohort study. Acta Oncologica 2020;59(8):988–93.
                  
                </li><li>Bray F, Carstensen B, Møller H, Zappa M, Zakelj MP, Lawrence G, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev 2005;14(9):2191–9.
                </li><li>Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG, Bulten J. Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol 2008;111(1):167–77.

                </li><li>Bosch FX, Robles C, Díaz M, Arbyn M, Baussano I, Clavel C, et al. HPV-FASTER: broadening the scope for prevention of HPV-related cancer. Nat Rev Clin Oncol 2016;13(2):119–32.
                  
                </li><li>Arbyn M, Haelens A, Desomer A, Verdoodt F, Thiry N, Francart J, et al. Cervical cancer screening program and human papillomavirus (HPV) testing, part II: update on HPV primary screening [Internet]. Brussels: Belgian Health Care Knowledge Centre (KCE); 2015. Disponible <a href="https://www.kce.fgov.be/en/cervical-cancer-screening-program-and-human-papillomavirus-hpv-testing-part-ii-update-on-hpv-primary" target="_blank">aquí <span class="icon solid fa-external-link-alt"></span></a>.
                  
                </li><li>Koliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PP, Mustafa RA, et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst Rev 2017;8:CD008587.
                  
                </li><li>Giorgi-Rossi P, Franceschi S, Ronco G. HPV prevalence and accuracy of HPV testing to detect high-grade cervical intraepithelial neoplasia. Int J Cancer 2012;130(6):1387–94.
                  
                </li><li>Dillner J, Rebolj M, Birembaut P, Petry K-U, Szarewski A, Munk C, et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 2008;337:a1754.
                  
                </li><li>Ronco G, Dillner J, Elfström KM, Tunesi S, Snijders PJF, Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 2014;383(9916):524–32.
                  
                </li><li>Loonen AJM, Huijsmans CJJ, Geurts-Giele WRR, Leeijen C, van der Linden JC, van den Brule AJC. Performance analysis of high-throughput HPV testing on three automated workflows. APMIS 2020;128(8):497–505.
                  
                </li><li>Davey E, Irwig L, Macaskill P, Chan SF, D’Assuncao J, Richards A, et al. Cervical cytology reading times: a comparison between ThinPrep Imager and conventional methods. Diagn Cytopathol 2007;35(9):550–4.
                  
                </li><li>Mendes D, Bains I, Vanni T, Jit M. Systematic review of model-based cervical screening evaluations. BMC Cancer 2015;15:334.
                  
                </li><li>Dillner J. Primary human papillomavirus testing in organized cervical screening. Curr Opin Obstet Gynecol 2013;25(1):11–6.
                  
                </li><li>Malagón T, Volesky KD, Bouten S, Laprise C, El-Zein M, Franco EL. Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis. Int J Cancer 2020;147(10):2695–707.
                  
                </li><li>Demarco M, Hyun N, Carter-Pokras O, Raine-Bennett TR, Cheung L, Chen X, et al. A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs. EClinicalMedicine 2020;22:100293.
                  
                </li><li>Bonde JH, Sandri M-T, Gary DS, Andrews JC. Clinical Utility of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Systematic Review. J Low Genit Tract Dis 2020;24(1):1–13.
                  
                </li><li>Sundström K, Dillner J. How many Human Papillomavirus types do we need to screen for? J Infect Dis 2020;
                  
                </li><li>Hortlund M, van Mol T, Van de Pol F, Bogers J, Dillner J. Human papillomavirus load and genotype analysis improves the prediction of invasive cervical cancer. Int J Cancer 2021;
                  
                </li><li>Cuzick J, Wheeler C. Need for expanded HPV genotyping for cervical screening. Papillomavirus Research 2016;2:112–5.

                </li><li>Schiffman M, Clifford G, Buonaguro FM. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agents Cancer 2009;4:8.

</li><li>Arbyn M, Simon M, Peeters E, Meijer CJLM, Berkhof J, Cuschieri K, et al. 2020 List of human papillomavirus assays Suitable for primary cervical cancer screening. Clinical Microbiology and Infection [Internet] 2021 [cited 2021 May 12];0(0). Disponible <a href="https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(21)00219-6/abstract" target="_blank">aquí <span class="icon solid fa-external-link-alt"></span></a>.

</li><li>Monsonego J, Hudgens MG, Zerat L, Zerat J-C, Syrjänen K, Smith JS. Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study). Gynecol Oncol 2012;125(1):175–80.

</li><li>Cook DA, Smith LW, Law JH, Mei W, Gondara L, van Niekerk DJ, et al. Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial. J Clin Virol 2018;108:32–7.

</li><li>Forslund O, Miriam Elfström K, Lamin H, Dillner J. HPV-mRNA and HPV-DNA detection in samples taken up to seven years before severe dysplasia of cervix uteri. Int J Cancer 2019;144(5):1073–81.

</li><li>Iftner T, Neis K-J, Castanon A, Landy R, Holz B, Woll-Herrmann A, et al. The longitudinal clinical performance of the RNA-based AHPV Human Papillomavirus (HPV) Assay in comparison to the DNA-based Hybrid Capture 2 HPV Test in 2 consecutive screening rounds with a 6-year interval in Germany. J Clin Microbiol 2018;

</li><li>Zorzi M, Del Mistro A, Giorgi Rossi P, Laurino L, Battagello J, Lorio M, et al. Risk of CIN2 or more severe lesions after negative HPV-mRNA E6/E7 overexpression assay and after negative HPV-DNA test: Concurrent cohorts with a 5-year follow-up. Int J Cancer 2020;146(11):3114–23.

</li><li>Meijer CJLM, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer 2009;124(3):516–20.

</li><li>Arbyn M, Depuydt C, Benoy I, Bogers J, Cuschieri K, Schmitt M, et al. VALGENT: A protocol for clinical validation of human papillomavirus assays. J Clin Virol 2016;76 Suppl 1:S14–21.

</li><li>Poljak M, Valenčak AO, Domjanič GG, Xu L, Arbyn M. Commercially available molecular tests for human papillomaviruses: a global overview. Clinical Microbiology and Infection [Internet] 2020 [cited 2020 Apr 8]. Disponible <a href="http://www.sciencedirect.com/science/article/pii/S1198743X20301798" target="_blank">aquí <span class="icon solid fa-external-link-alt"></span></a>.

</li><li>Tota JE, Bentley J, Blake J, Coutlée F, Duggan MA, Ferenczy A, et al. Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm. Prev Med 2017;98:5–14.

</li><li>Bulkmans NWJ, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJP, Bulk S, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007;370(9601):1764–72.

</li><li>WHO | Public reports of WHO prequalified IVDs (HPV virological technologies) [Internet]. WHO [cited 2021 Feb 3]. Disponible <a href="http://www.who.int/diagnostics_laboratory/evaluations/pq-list/public_report_hpv/en/" target="_blank">aquí <span class="icon solid fa-external-link-alt"></span></a>.

</li><li>Sargent A, Bailey A, Almonte M, Turner A, Thomson C, Peto J, et al. Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial. Br J Cancer 2008;98(10):1704–9.
</li><li>Gillio-Tos A, De Marco L, Carozzi FM, Del Mistro A, Girlando S, Burroni E, et al. Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) study. J Clin Microbiol 2013;51(9):2901–7.

</li><li>Kuhn L, Saidu R, Boa R, Tergas A, Moodley J, Persing D, et al. Clinical evaluation of modifications to a human papillomavirus assay to optimise its utility for cervical cancer screening in low-resource settings: a diagnostic accuracy study. The Lancet Global Health 2020;8(2):e296–304.
        </li>        </ol>
              <hr />
      <!-- Section -->
      <section class="main">

        <header class="major">
          <h2>MÓDULO 3</h2>
        </header>
        <div class="featuresB">
          <section>
            <a href="M31_1.html"
              ><span class="icon solid fa-female major accent4"></span
            ></a>
            <h3><a href="M31_1.html" class="button">UNIDAD 1</a></h3>
            <a href="M31_1.html"><p>Introducción</p></a>
          </section>
          <section>
            <a href="M32_1.html"
              ><span class="icon solid fa-microscope major accent4"></span
            ></a>
            <h3><a href="M32_1.html" class="button">UNIDAD 2</a></h3>
            <a href="M32_1.html"><p>Citología</p></a>
          </section>
          <section>
            <a href="M33_1.html"
              ><span class="icon solid fa-search major accent4"></span
            ></a>
            <h3><a href="M33_1.html" class="button">UNIDAD 3</a></h3>
            <a href="M33_1.html"><p>Pruebas de VPH</p></a>
          </section>
          <section>
            <a href="M34_1.html"
              ><span class="icon solid fa-user-md major accent4"></span
            ></a>
            <h3><a href="M34_1.html" class="button">UNIDAD 4</a></h3>
            <a href="M34_1.html"><p>Pruebas de cribado primarias</p></a>
          </section>
        </div>
        <hr />

        <header class="major">
          <h2>RECURSOS</h2>
        </header>
        <div class="featuresA">
          <section>
            <a href="M3summary.html"
              ><span class="icon solid fa-star major accent4"></span
            ></a>
            <h3><a href="M3summary.html" class="button">Resumen</a></h3>
          </section>
          <section>
            <a href="M3biblio.html"
              ><span class="icon solid fa-book major accent4"></span
            ></a>
            <h3><a href="M3biblio.html" class="button">Bibliografía</a></h3>
          </section>
          <section>
            <a href="docs/PDF_03.pdf" target="_blank"
              ><span class="icon solid fa-file major accent4"></span
            ></a>
            <h3>
              <a href="docs/PDF_03.pdf" target="_blank" class="button"
                >PDF</a
              >
            </h3>
          </section>
        </div>
       
      </section>
    </div>
  </div>

   <!-- Wrapper -->
   <div class="wrapper">
    <div class="inner">
      <!-- Footer -->
      <footer id="footer">
        <div class="image">
          <a href="https://www.e-oncologia.org/" target="_blank"><img src="images/logos.png" alt="" data-position="" /></a>
        </div>
      </footer>
    </div>
  </div>
</div>

<!-- Scripts -->
<script src="assets/js/jquery.min.js"></script>
<script src="assets/js/browser.min.js"></script>
<script src="assets/js/breakpoints.min.js"></script>
<script src="assets/js/util.js"></script>
<script src="assets/js/main.js"></script>
</body>
</html>